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Abstract
Background: The mechanism by which Hsp40 and other molecular chaperones recognize and
interact with non-native polypeptides is a fundamental question. How Hsp40 co-operates with
Hsp70 to facilitate protein folding is not well understood. To investigate the mechanisms, we
determined the crystal structure of the putative peptide-binding fragment of Hdj1, a human
member of the type II Hsp40 family.
Results:  The 2.7Å structure reveals that Hdj1 forms a homodimer in the crystal by a
crystallographic two-fold axis. The Hdj1 dimer has a U-shaped architecture and a large cleft is
formed between the two elongated monomers. When compared with another Hsp40 Sis1
structure, the domain I of Hdj1 is rotated by 7.1 degree from the main body of the molecule, which
makes the cleft between the two Hdj1 monomers smaller that that of Sis1.
Conclusion:  This structural observation indicates that the domain I of Hsp40 may possess
significant flexibility. This flexibility may be important for Hsp40 to regulate the size of the cleft. We
propose an "anchoring and docking" model for Hsp40 to utilize the flexibility of domain I to interact
with non-native polypeptides and transfer them to Hsp70.
Background
Molecular chaperones are a large group of proteins that
can bind and stabilize non-native polypeptides and facil-
itate protein folding into their native conformations [1-3].
Heat shock protein 70s (Hsp70s) play essential roles in
cell physiology and have been well studied [1-3]. Mem-
bers of the Hsp70 and Hsp40 (DnaJ-like) families func-
tion in specific pairs that form transient complexes with
non-native regions of polypeptides to promote the fold-
ing, assembly and transport of proteins within the cell [1-
7].
All types of Hsp40 proteins contain a J-domain that can
stimulate the ATPase activities of Hsp70. Both type I and
type II Hsp40s have a peptide-binding fragment located at
the C-terminus of the proteins. The N-terminal J-domains
are connected to the peptide-binding fragments via a G/F
rich linker in both type I and type II Hsp40s. Type I Hsp40
such as E. coli DnaJ, yeast Ydj1 and human Hdj2 contain
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two Zinc-finger motifs between the J-domain and the C-
terminal peptide-binding fragment while type II Hsp40
proteins such as human Hdj1 and yeast Sis1 do not [8-
10]. It was proposed that Hsp40 binds non-native
polypeptide first and then delivers the non-native
polypeptide to Hsp70 for folding [1,11,12]. The ability to
bind non-native polypeptides for the cytosolic Hsp40 is
an essential function in vivo [13].
The crystal structures of the peptide-binding fragments of
Ydj1 and Sis1, the type I and II Hsp40 proteins from S. cer-
evisiae, was determined to 2.7 Å resolution, respectively
[14-17]. The crystal structures revealed that both Ydj1 and
Sis1 peptide-binding fragments functioned as a homo-
dimer with a large cleft between the two elongated mono-
mers. The Sis1 monomer contains domain I, II and a short
C-terminal dimerization motif. A hydrophobic depres-
sion was revealed as the putative peptide-binding site on
the molecular surface of the domain I of Sis1 monomer
[14,17]. In the crystal structure of Ydj1 complexed with
the peptide substrate, the domain I and domain III of Ydj1
resemble the structure of domain I and II of Sis1 while two
Zinc finger motifs form the domain II of Ydj1 [15,16]. The
peptide substrate binds to the domain I of Ydj1 and form
a β-strand with the Ydj1 molecule. The side chains of the
peptide substrate make extensive hydrophobic interac-
tions with a hydrophobic pocket located on domain I of
Ydj1.
It has been showed that the extreme C-terminal four
amino acid residues EEVD within human Hsp70 play reg-
ulatory roles in Hsp40/Hsp70 functions [4]. Deletion of
these four residues compromised the protein refolding
capability of human Hsp70 facilitated by the human
Hsp40 Hdj1 [4,6]. The crystal structure of Sis1 peptide-
binding fragment complexed with the Hsp70 Ssa1 C-ter-
minus has been determined [7]. The Ssa1 extreme C-ter-
minal eight amino acid residues GPTVEEVD form a β-
strand with the domain I of Sis1 peptide-binding frag-
ment. The Ssa1 C-terminus binds Sis1 at the site where
Sis1 interacts with the non-native polypeptides.
The human type II Hsp40 Hdj1 has been shown to func-
tion as a molecular chaperone to promote efficient pro-
tein folding. Hdj1 can bind to the non-native polypeptide
and suppress the protein aggregation. Hdj1 can also pair
with Hsp70 to refold the non-native polypeptides [4,18].
Both of human Hdj1 and yeast Sis1 belong to type II
Hsp40 family and they might have similar in vivo func-
tions [19]. The crystal structure of Hdj1 presented in this
paper may reveal the mechanism by which Hdj1 func-
tions as a molecular chaperone to promote protein fold-
ing.
Results
Structure determination of the human Hsp40 Hdj1 
putative peptide-binding fragment
We have expressed and purified the human type II Hsp40
Hdj1 putative peptide-binding fragment (residues 158–
340). The protein was then crystallized by use of hanging
drop vapor diffusion method. The crystal structure of the
Hdj1 putative peptide-binding fragment was determined
to 2.7Å resolution by the molecular replacement method
using the Sis1 structure as the search model (Table I). The
resultant electron density map from the molecular
replacement method allowed us to trace the residues 162
to 335 of Hdj1 except for a short loop region (residues
228 to 230).
Hdj1 putative peptide-binding fragment forms a dimer in
the crystal structure. The two monomers are related by a
crystallographic two-fold axis. The structure of the Hdj1
(156–340) monomer consists of eleven β-strands (B1-
B11) and three short α-helixes (A1-A3; Fig. 1). The Hdj1
monomer structure contains domain I, II and the C-termi-
nal dimerization motif. Both domain I and II have a core
formed by a major β-sheet and a minor β-sheet that are
connected by a short helix. The two Hdj1 monomers are
associated into a homo-dimer through the C-terminal
dimerization motif (Fig. 1). The Hdj1 homo-dimer forms
a U-shaped architecture and a large cleft is formed
between the two elongated monomers.
The comparison between Human Hsp40 Hdj1 and yeast 
Hsp40 Sis1 structures
We have previously determined the crystal structure of
yeast type II Hsp40 Sis1 peptide-binding fragment at 2.7
Table 1: Statistics for Hdj1 data collection and structure 
determination (Numbers in parenthesis are for the outer 
resolution shell.)
Hdj1 fragment
Data collection
Resolution (Å) 2.7 (2.81-2.70)
Rsym 0.065(0.382)
I/σI 18.1(2.1)
Completeness (%) 89.8%(65.9%)
Redundancy 5.7
Refinement
Resolution (Å) 30.0-2.7
No. reflections 9943 (681 used for Rfree calculation)
Rwork 28.3 (38.8)
Rfree 33.6 (42.3)
R.m.s deviations
Bond lengths (Å) 0.01
Bond angles (°) 1.50
Impropers (°) 1.09
Dihedrals (°) 25.8BMC Structural Biology 2008, 8:3 http://www.biomedcentral.com/1472-6807/8/3
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Å resolution [14]. Therefore, it is of interest to compare
these two Hsp40 protein structures from different species
(Fig. 2). Both Hdj1 and Sis1 monomer structures contain
domain I, domain II and the C-terminal dimerization
motif. The individual domains from Hdj1 and Sis1 struc-
ture share similar folds. The Hdj1 dimer and Sis1 dimer
have a similar U-shaped molecular shape with a large cleft
between the monomers (Fig. 2).
However, significant differences exist between Hdj1 and
Sis1 structures. When the domain II of Hdj11 is superim-
posed with that of the Sis1 structure, we found that the
domain I of Hdj1 in the complex structure was kinked
about 7.1° away from that in Sis1 structure (Fig. 2). The
domain re-arrangements within Hdj1 were achieved by
the rotation of the linker region between domain I and
domain II (residues 242 to 249).
The domain arrangements between domain I and II of
Hdj1 cause the two domain Is within the Hdj1 dimer
closer to each other when compared with Sis1 structure
(Fig. 2). This makes the cleft between two monomers
within Hdj1 smaller than that of Sis1. The relative posi-
tions of the domain IIs and the C-terminal dimerization
motifs within the Hdj1 and Sis1 homo-dimers, however,
are kept almost the same when superimposed (Fig. 2). The
structural differences between Hdj1 and Sis1 structures
indicate that the domain I of Hsp40 may possess signifi-
cant flexibility. This flexibility may be important for
Hsp40 to interact with non-native polypeptides and trans-
fer them to Hsp70.
Another major difference between Hdj1 and Sis1 structure
is at the tip region of the domain I. The sequence align-
ment indicates that human Hsp40 Hdj1 has five more
amino acid residues between β-strand B2 and B3 than Sis1
from yeast, while Hdj1 has one fewer residue between β-
strand B4 and B5 than Sis1 (Fig. 3). When the domain Is
from Hdj1 and Sis1 structures are superimposed, we
found that the loop between B2 and B3 in Hdj1 structure
The crystal structure of the Hdj1 putative peptide-binding fragment Figure 1
The crystal structure of the Hdj1 putative peptide-binding fragment. a) Ribbon drawing of the Hdj1 putative peptide-binding 
fragment homo-dimer [27]. One monomer of the Hdj1 is shown in silver and the other monomer is shown in gold. The two 
monomers are related by a vertical two-fold axis. The missing short loop region (residues 228 to 230) is indicated by a dotted 
line. Domain I and II of Hdj1 are labeled. The N-terminus and C-terminus of Hdj1 are also labeled. b) A view of Hdj1 dimer 
after it is rotated 90° along the vertical axis from the orientation shown in Fig. 1a.BMC Structural Biology 2008, 8:3 http://www.biomedcentral.com/1472-6807/8/3
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protrudes significantly further away than that in Sis1
structure. The longer loop region at the tip of domain I in
the Hdj1 structure helps to constitute a larger domain I
than that in Sis1 structure. Sequence alignment shows that
the loop region between B2 and B3 is longest for human
and mouse type II Hsp40 among all species. It is two
amino acid residues shorter in C. elegans and Drosophila
and five amino acid residues shorter in yeast S. cerevisiae
(Fig. 3).
On the other hand, the loop region between B4 and B5 in
Hdj1 is one residue shorter than that in Sis1 structure (Fig.
3). Because part of the electron density is missing for this
loop region in Hdj1 structure, it is difficult for us to com-
pare this region between Hdj1 and Sis1 structure. The
sequence alignment indicates that only Sis1 from S. cere-
visiae has the longer loop between B4 and B5. All the other
type II Hsp40s, however, contain the shorter version of
the loop between B4 and B5.
The peptide-binding site of human Hsp40 Hdj1
Molecular chaperone Hsp40 can interact and stabilize the
non-native polypeptides and prevent them from forming
aggregations. The peptide-binding sites of both type I and
type II Hsp40s for the non-native polypeptides have been
located on the molecular surface of domain I. The Hsp40s
may bind the non-native polypeptides through hydro-
phobic interactions [14-16]. When we examined the pep-
tide-binding site on the domain I of Hdj1 structure,
several hydrophobic residues were identified to partici-
pate in forming the peptide-binding site. These residues
include L168, M183, I185 and F237 (Fig. 4). The hydro-
phobicity of these residues is well conserved among all
species. However, a polar residue, H166, was also identi-
fied to be involved in constituting the peptide-binding
pocket (Fig. 4). This Histidine residue is conserved for
type II Hsp40s among all species except for yeast as shown
in sequence alignment (Fig. 3). We reason that H166 may
play an important role in positioning the side chains from
Pro, Phe or Tyr residues through van der waals interac-
tions.
Hsp40 and Hsp70 form transient complex to facilitate the
efficient protein folding process [4,6]. It has been reported
that Hsp40 may interact with the Hsp70 C-terminal EEVD
motif by use of the peptide-binding site located on Hsp40
domain I [7]. The crystal structure of yeast Hsp40 Sis1 and
Hsp70 Ssa1 C-terminus complex indicated that several
Lysine residues (K199, K202, K214 and K256) in Sis1 are
involved in binding the Hsp70 C-terminal EEVD motif by
charge-charge interactions. The sequence alignment
shows that the corresponding residues in Hdj1 are K181,
K184, R198 and K242. In the Hdj1 structure, K181, K184
and K242 are well-positioned to interact with the EEVD
motif from Hsp70 (Fig. 4). K181 and K242 are stabilized
by forming salt bridges with a conserved E174. R198,
however, points to the opposite direction from the pep-
tide-binding site of Hdj1 and it is not likely to be involved
The structural comparison between Hdj1 and Sis1 Structures in Ribbon drawings Figure 2
The structural comparison between Hdj1 and Sis1 Structures in Ribbon drawings. a) The Hdj1 structure is superimposed with 
the Sis1 structure after the domain II of Hdj1 is aligned with that in the Sis1. The color definition of Hdj1 homo-dimer is the 
same as that in Fig. 1. Sis1 structure is in blue. The Hdj1 dimer is shown while only the Sis1 monomer is drawn in this figure. b) 
A view of Hdj1 and Sis1 structures after they are rotated 90° along the vertical axis from the orientation shown in Fig. 2a. Only 
Hdj1 and Sis1 monomer structures are shown in this figure for clarity. c) A stereo view of Hdj1 and Sis1 structures after they 
are rotated 90° along the horizontal axis from the orientation shown in Fig. 2a. The cleft faces readers. The Hdj1 dimer is 
shown while only the Sis1 monomer is drawn in this figure.BMC Structural Biology 2008, 8:3 http://www.biomedcentral.com/1472-6807/8/3
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in binding Hsp70 EEVD. K181, K184 and K242 are all
conserved for type II Hsp40 among all species. Therefore
these positively charged residues may be the common res-
idues for type II Hsp40s to interact with the Hsp70 C-ter-
minal EEVD motifs.
Discussion
We report the crystal structure of human type II Hsp40
Hdj1 putative peptide-binding fragment to 2.7Å resolu-
tion. The structure reveals that Hdj1 forms a homo-dimer
in the crystal by a crystallographic two-fold axis. The Hdj1
dimer has a U-shaped architecture and a large cleft is
formed between the two elongated monomers. The
human Hdj1 structure is similar to the S. cerevisiae Hsp40
Sis1, which may account for the fact that Hdj1 and Sis1
share similar in vivo functions [19]. However, the two
structures have significant differences. When compared
with yeast type II Hsp40 Sis1 structure, the domain I of
Hdj1 shows a 7.1° rotation from the main body of the
molecule, which makes the cleft between two Hdj1 mon-
omers smaller. In the crystal structure of Hdj1, a polar res-
idue H166 is involved in forming the peptide-binding
site, which is different from the hydrophobic peptide-
binding depression revealed in Sis1 structure. In addition,
at the tip of domain I in Hdj1 structure, Hdj1 structure has
Sequence alignment of the C-terminal regions from eukaryotic Type II Hsp40 family members Figure 3
Sequence alignment of the C-terminal regions from eukaryotic Type II Hsp40 family members. Program Pileup from GCG 
package was utilized to align residues 162–340 of Hdj1 from H. sapiens with similar regions of Hsp40 proteins from M. musculus 
(Hsp40-3), C. elegans (Z66513.1), D. Melanogaster (Droj-1), S. pombe (Psi protein) and S. cerevisiae (Sis1). The amino acid resi-
due numbers of Hdj1 are numbered above the alignment. The residues involved in forming the peptide-binding site of Hdj1 are 
marked by blue bars. The secondary structures of Hdj1 are shown on top of the alignment. The structural components in 
domain I are denoted by blue and those in domain II are denoted by green. The α-helices are represented by boxes and β-
strands are represented by arrows.BMC Structural Biology 2008, 8:3 http://www.biomedcentral.com/1472-6807/8/3
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a longer loop region than Sis1, which accounts for a larger
domain I in Hdj1 structure.
The domain re-arrangement between domain I and
domain II within type II Hsp40 has been observed when
yeast Hsp40 Sis1 binds the Hsp70 Ssa1 C-terminus. Little
conformational changes occur within the individual
domain I and domain II of Sis1 after binding to Ssa1.
However, we found that the domain I of Sis1 in the com-
plex structure was kinked about 8.5° away from that in
Sis1 structure. These conformational changes widen up
the cleft between the two Sis1 monomers within the
homo-dimer, where might be the docking site for Ssa1
peptide-binding domain [7]. In contrast, when we com-
pare the crystal structures of Hdj1 and Sis1 peptide-bind-
ing fragment, we found that the domain Is within Hdj1
were swung towards each other by 7.1° from that in Sis1
structure, which makes the cleft between the two mono-
mers smaller. These domain re-arrangements were
achieved by the rotation of the linker region between
domain I and domain II within both Sis1 and Hdj1 struc-
tures. The relative positions of the domain IIs within the
Sis1 and Hdj1 dimer, however, are kept almost the same.
These structural observations indicate that domain I of
Hsp40 may possess significant flexibility to take different
conformations for its molecular chaperone activity. The
flexibility in Sis1 could be important for the Hsp40/
Hsp70 system to function. Previous studies have shown
that the mutations within the interface of domain I and
domain II in Sis1 can abolish the binding capability of
Sis1 to Ssa1 [20]. It is possible that the conformational
changes of Sis1 can not be achieved within these mutants
to locate the domain I of Sis1 into the Ssa1 binding posi-
tion.
In the Sis1 structure, the peptide-binding site is occupied
by a Pro residue from a neighbor molecule. It is possible
that the Sis1 structure may represent the conformation for
Sis1 to bind the non-native polypeptide. The Sis1-Ssa1
complex structure may represent the conformation for
Sis1 to interact with Hsp70 Ssa1. The peptide-binding site
in the Hdj1 structure is not occupied by any amino acid
residue, so the Hdj1 structure may represent the free
Hsp40 state. Thus, Hsp40 may take different conforma-
tions in these three states.
An "anchoring and docking" model for Hsp70 to interact
with Hsp40 Sis1 has been proposed, in which the Hsp70
C-terminus may function as an anchor to bind to Hsp40
[6,7]. The studies in this paper may add significant more
details into the model (Fig. 5). When the Hsp40 is free of
non-native polypeptides, it may keep a relatively small
cleft within the dimer structure. The cleft may be widened
The surface potential drawings around the Hdj1 and Sis1 peptide-binding sites determined by Swiss-PDBviewer Figure 4
The surface potential drawings around the Hdj1 and Sis1 peptide-binding sites determined by Swiss-PDBviewer. Blue and red 
denote positively and negatively charged regions, respectively. a) Surface potential drawing presentation of the Hdj1 peptide-
binding site. The residues of Hdj1 involved in forming the peptide-binding site are labeled in black. The Lysine residues involved 
in binding the Hsp70 C-terminal EEVD motifs are labeled in white. b) Surface potential drawing presentation of the Sis1 pep-
tide-binding site.BMC Structural Biology 2008, 8:3 http://www.biomedcentral.com/1472-6807/8/3
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Schematic representation of the "anchoring and docking" mechanism by which Hsp40 (green) delivers a non-native peptide  (blue) to Hsp70 (yellow) Figure 5
Schematic representation of the "anchoring and docking" mechanism by which Hsp40 (green) delivers a non-native peptide 
(blue) to Hsp70 (yellow). The cartoon drawing depicts an Hsp70 molecule that is divided into its ATPase domain, peptide-bind-
ing groove and the lid domain. The J-domain and peptide-binding fragment of Hsp40 are shown schematically. The C-terminus 
"anchor" region of Hsp70 is shown in a red arrow. The blue line denotes the extended non-native polypeptide. The thick black 
region in the non-native polypeptide indicates the hydrophobic region that can be recognized by Hsp40 peptide-binding frag-
ment and Hsp70 peptide-binding domain. a) When Hsp40 is free of the non-native polypeptide, the cleft between the two 
monomers is narrow. b) The cleft is widened up when Hsp40 binds the non-native polypeptide. This may help to stretch the 
polypeptides into the extended conformations. c) The cleft within Hsp40 is further opened up when the Hsp70 C-terminus 
interacts with the Hsp40. d) When the Hsp70-non-native polypeptide complex is released from Hsp40, the cleft within Hsp40 
returns to the narrow state.BMC Structural Biology 2008, 8:3 http://www.biomedcentral.com/1472-6807/8/3
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up when Hsp40 binds the non-native polypeptide. The
Hsp70 C-terminal anchor region may bind the Sis1 pep-
tide-binding pocket and replace hydrophobic side chains
from the non-native polypeptide. This may further widen
up the cleft within Hsp40 homo-dimer. The freed non-
native polypeptide may be bound by Hsp70 for subse-
quent protein folding (Fig. 5).
The low resolution quaternary structures of full-length
type I and type II Hsp40s have been determined by small
angle X-ray scattering [21]. The small angel X-ray scatter-
ing studies indicated that the two J-domains within the
type II Hsp40 dimer are positioned at two opposite ends.
The relative positioning of Hsp70 N-terminal domain and
C-terminal domain has also been revealed by X-ray crys-
tallography [22]. Our working model is consistent with
the results from previous structural studies.
It is not very clear what roles that the Hsp40 conforma-
tional changes may play when binding the non-native
polypeptides in Hsp40/Hsp70 molecular chaperone func-
tions. Several possibilities may exist. 1. Widening up the
cleft while Hsp40 interacts with non-native polypeptides
may help to stretch the polypeptides into extended con-
formations. Hsp70 prefers to bind the polypeptides in
extended conformations. 2. The enlarged cleft within the
Hsp40 homo-dimer may provide more space for Hsp70 to
dock and to interact with the non-native polypeptides.
Conclusion
We have determined the crystal structure of the putative
peptide-binding fragment of Hdj1, a human member of
the type II Hsp40 family. The 2.7Å structure reveals that
Hdj1 forms a homodimer in the crystal by a crystallo-
graphic two-fold axis. The Hdj1 dimer has a U-shaped
architecture and a large cleft is formed between the two
elongated monomers.
This structural observation indicates that the domain I of
Hsp40 may possess significant flexibility. This flexibility
may be important for Hsp40 to regulate the size of the
cleft. We propose an "anchoring and docking" model for
Hsp40 to utilize the flexibility of domain I to interact with
non-native polypeptides and transfer them to Hsp70.
Methods
Crystallization of the Hdj1 putative peptide-binding 
fragment
We have cloned the human type II Hsp40 Hdj1 putative
peptide-binding fragment (residues 158–340). The
recombinant protein was then expressed in E. coli and
purified by use of a Nickel-chelating column followed by
a gel filtration column Superdex-75 (GE Healthcare). The
protein was concentrated to 25 mg/ml in 10 mM Tris
buffer (pH 8.0), NaCl 50 mM. The Hdj1 putative peptide-
binding fragment was crystallized by use of hanging drop
vapor diffusion method with the mother liquid of 100
mM Citric acid buffer (pH 5.5), 25% PEG400 at room
temperature.
Structure determination and refinement
The diffraction data for the Hdj1 crystals were collect at
APS beamline SERCAT. The crystals were flash frozen at
100 K in a nitrogen gas stream in the cryoprotectant con-
sisting of 100 mM citric acid buffer (pH 5.5), 35%
PEG400. The crystals diffracted to 2.7Å using the X-ray at
1.0Å wavelength. The data were processed by HKL2000
package. The crystals belong to the space group of C2221
with the cell parameters of a = 97.01Å, b = 191.13 and c =
40.96Å.
Program EPMR through the package SGXPRO was utilized
to carry out the molecular replacement method [23]. The
Sis1 peptide-binding fragment monomer structure was
used as the searching model. The sequence identity
between Sis1 and Hdj1 peptide-binding fragment is 33%.
One clear solution was revealed through the search. The
resultant electron density map allowed us to carry out the
molecular tracing by use of the program O [24]. The resi-
dues 162 to 335 of Hdj1 except for a short loop region
(residues 228 to 230) were modeled into the electron den-
sity map.
The model was then refined by program CNS against the
2.7Å data collected at APS [25]. One cycle of temperature
annealing at 2000 K and six cycles of positional refine-
ment were then carried out. Restrained individual B-factor
refinement was not performed until the last cycle. After
each cycle of refinement, the model was manually rebuilt
according to the resultant 2Fo-Fc and Fo-Fc maps. The
refinement gave reasonable R.M.S. derivation from the
ideal geometry at this resolution (Table 1). The possible
bias for Hdj1 structure determination generated by using
Sis1 as a model is not very likely because we see clear side
chains for Hdj1 molecule in the resultant electron density
map. The Rfree is also within the reasonable range, which
indicates the Hdj1 structure is correct.
A Ramachandran plot of the final model by use of pro-
gram Probity revealed that 87.7% of the residues in the
structure were in the favored regions and 97.2% of the res-
idues were in allowed regions [26].
Coordinates
The coordinates and structure factors of Hdj1 putative
peptide-binding fragment crystals have been deposited to
Protein Data Bank with an accession number of 2QLD.Publish with BioMed Central    and   every 
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